Federal – Other

Crisis Standards of Care and Civil Rights Laws (NASEM/DHS OCR/FEMA)

Enrollment
COVID-19 Medicare Provider Enrollment Relief FAQs

Workforce
COVID-19 Workforce Virtual Toolkit: Resources for Healthcare Decision-Makers Responding to COVID-19 Workforce Concerns

Preliminary Medicare COVID-19 Data Snapshot

Administration of COVID Vaccines by Pharmacists and Pharmacy Interns
HHS Guidance for Licensed Pharmacists and Pharmacy Interns Regarding COVID-19 Vaccines and Immunity under the PREP Act (9/3/20)

OCR Anti-Discrimination Bulletin
Office of Civil Rights Bulletin: Civil Rights Protections Prohibiting Race, Color and National Origin Discrimination During COVID‐19 (7/20/20)

OIG Strategic Plan: Oversight of COVID-19 Response and Recovery (5/26/20)

CMS Clinician Letter re MIPS
CMS letter to Clinicians participating in MIPS (4/28/20)

PACE Organization FAQ
CMS Responses to Questions Asked During the March 24, 2020 Call with the Programs of All-Inclusive Care for the Elderly Community (Clinical Concerns, Staffing, Enrollment, Telehealth, Quality & Reporting, and Billing & Payment) (4/9/20)

Human Subjects Research
Office for Human Research Protections Guidance on COVID-19 (4/8/20)

CMS Clinician Letter
Dear Clinician Letter re: CMS Response and Resources (4/7/20)

OIG—Hospital Experiences
Hospital Experiences Responding to the COVID-19 Pandemic: Results of a National Pulse Survey March 23–27, 2020 (4/6/20)

OIG Policy Statement (Anti-Kickback Statute Enforcement)
OIG Policy Statement Regarding Application of Certain Administrative Enforcement Authorities Due to Declaration of COVID-19 Outbreak in the United States as a National Emergency (Federal Anti-Kickback Statute) (4/3/20)

DEA Guidance
DEA Telemedicine Questions & Answers

    > Use of Telephone Evaluations to Initiate Buprenorphine Prescribing (3/31/20)

Medicare Appeals
PRRB Alert 19: Temporary COVID-19 Adjustments to PRRB Processes (3/25/20)

Antitrust
DOJ – FTC Joint Antitrust Statement Regarding COVID-19 (3/24/20)

OIG—Fraud
A Message from OIG HHS Leadership on COVID-19 Fraud, including OIG COVID-19 Fraud Alert (3/23/20)

OIG Policy Statement on Telehealth Cost-Sharing Waivers
OIG Policy Statement and Fact Sheet Regarding Practitioners That Reduce or Waive Amounts Owed by Federal Health Care Program Beneficiaries for Telehealth Services During the 2019 Novel Coronavirus (COVID-19) Outbreak (3/17/20)

    > OIG FAQ on Telehealth Cost-Sharing Waivers